Lv413
418 积分 2024-02-28 加入
Correction to “Discovery Process of Enlicitide, a Highly Engineered Macrocyclic Peptide Therapeutic, Through Issue Driven Fragment-Based Synthetic Assembly and SAR”
7天前
已完结
Discovery of the Potent and Selective MC4R Antagonist PF-07258669 for the Potential Treatment of Appetite Loss
8天前
已完结
The pharmacological basis for nonpeptide agonism of the GLP-1 receptor by orforglipron
14天前
已完结
Characterization of Escherichia coli RNase H Discrimination of DNA Phosphorothioate Stereoisomers
25天前
已完结
RNA interference in the era of nucleic acid therapeutics
26天前
已完结
Chemistry, structure and function of approved oligonucleotide therapeutics
1个月前
已完结
Discovery and Optimization of First-in-Class Furopyrimidine-Based Inhibitors of Henipaviruses
1个月前
已完结
Design, Optimization, and Biological Evaluation of First-in-Class Triple Inhibitors of SGLT1, SGLT2, and DPP4 for Type 2 Diabetes Mellitus
1个月前
已完结
Discovery of Pyrazole-Containing RGD Mimics with Anti-Fibrotic Efficacy in the Unilateral Ureteral Obstruction Mouse Model
1个月前
已完结
Discovery of Potential First-in-Class Dual Ligand-Directed Degrader and Antagonist of the Androgen Receptor: BMS-986365
1个月前
已完结